Oracle earned a Leader designation in the "IDC MarketScape: Worldwide Life Sciences R&D RWD/RWE for Data Platforms, Technology Solutions, and Consulting Services 2026 Vendor Assessment." The report highlights Oracle's experience in providing real-world data (RWD) and real-world evidence (RWE) solutions. These solutions assist clients with regulatory submissions, market access, and product commercialization.
The assessment recognizes Oracle's four-decade history in the sector. Oracle aggregates electronic health record data following the Cerner acquisition. The company launched a new AI-powered life sciences platform in 2026. IDC noted Oracle's integrated offering of data, technology, and expertise equips life sciences organizations. This offering helps maximize the value and scale of their real-world evidence initiatives. Oracle's platform utilizes a dataset of over 122 million de-identified patient records.